The effect of frequent whole blood donation on ferritin, hepcidin, and subclinical atherosclerosis

Transfusion

Volumn 53, Issue 7, 2013, Pages 1468-1474

  Peffer, Karlijn ^a   Den Heijer, Martin ^a   Holewijn, Suzanne ^a   De Graaf, Jacqueline ^a   Swinkels, Dorine W ^a   Verbeek, André L M ^a   Atsma, Femke ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; FEMALE; HUMAN; IRON DEPLETION; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SMOKING;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; ATHEROSCLEROSIS; BLOOD DONORS; COHORT STUDIES; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED;

EID: 84880250035     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03916.x     Document Type: Article

References (32)

1. Sullivan JL,. Iron and the sex difference in heart disease risk. Lancet 1981; 1: 1293-1294.
2. Tuomainen TP, Loft S, Nyyssonen K, Punnonen K, Salonen JT, Poulsen HE,. Body iron is a contributor to oxidative damage of DNA. Free Radic Res 2007; 41: 324-328.
3. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J,; American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004; 109: 2617-2625.
4. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW,. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011; 57: 1650-1669.
5. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL,; NHLBI Retrovirus Epidemiology Donor Study-II. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2010; 51: 511-522.
6. Finch CA, Cook JD, Labbe RF, Culala M,. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977; 50: 441-447.
7. Abdullah SM,. The effect of repeated blood donations on the iron status of male Saudi blood donors. Blood Transfus 2011; 9: 167-171.
8. Simon TL, Garry PJ, Hooper EM,. Iron stores in blood donors. JAMA 1981; 245: 2038-2043.
9. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F,. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-3307.
10. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K,. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998; 148: 445-451.
11. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ,. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103: 52-57.
12. Meyers DG, Jensen KC, Menitove JE,. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42: 1135-1139.
13. Zheng H, Cable R, Spencer B, Votto N, Katz SD,. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 2005; 25: 1577-1583.
14. Engberink MF, Geleijnse JM, Durga J, Swinkels DW, de, Kort WL, Schouten EG, Verhoef P,. Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis 2008; 196: 856-862.
15. Simon A, Chironi G, Levenson J,. Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J 2007; 28: 2967-2971.
16. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A,. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005; 111: 310-314.
17. Bots ML, Dijk JM, Oren A, Grobbee DE,. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002; 20: 2317-2325.
18. Hoogendoorn EH, Hermus AR, de, Vegt F, Ross HA, Verbeek AL, Kiemeney LA, Swinkels DW, Sweep FC, den, Heijer M,. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52: 104-111.
19. Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de, Graaf J,. The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab 2009; 94: 2893-2899.
20. ter Avest E, Holewijn S, Bredie SJ, van, Tits LJ, Stalenhoef AF, de, Graaf J,. Pulse wave velocity in familial combined hyperlipidemia. Am J Hypertens 2007; 20: 263-269.
21. Friedewald WT, Levy RI, Fredrickson DS,. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van, Tienoven TD, Wetzels JF, Kiemeney LA, Sweep FC, den, Heijer M, Swinkels DW,. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011; 117: e218-225.
23. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, Peters HP, van, Dongen-Lases E, Wetzels JF, Sweep FC, Tjalsma H, Swinkels DW,. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010; 56: 1570-1579.
24. Sullivan JL,. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood) 2007; 232: 1014-1020.
25. Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, Yahiro M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T,. Hepcidin as well as TNF-alpha are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant 2011; 26: 2663-2667.
26. Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, Bertelli C, Fatta E, Bignamini D, Rametta R, Fargion S, Fracanzani AL,. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2010; 21: 568-575.
27. Valenti L, Dongiovanni P, Motta BM, Swinkels DW, Bonara P, Rametta R, Burdick L, Frugoni C, Fracanzani AL, Fargion S,. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol 2011; 31: 683-690.
28. Atsma F, Veldhuizen I, Verbeek A, de, Kort W, de, Vegt F,. Healthy donor effect: its magnitude in health research among blood donors. Transfusion 2011; 51: 1820-1828.
29. Simon A, Megnien JL, Chironi G,. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010; 30: 182-185.
30. Peters SA, Grobbee DE, Bots ML,. Carotid intima-media thickness: a suitable alternative for cardiovascular risk as outcome? Eur J Cardiovasc Prev Rehabil 2011; 18: 167-174.
31. Zoungas S, Asmar RP,. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 2007; 34: 647-651.
32. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, McDermott MM, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.